JRI logo

JRI EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported29.51%
JRI TTM EBITDA YoY % (-8.07% → 29.51%)
High-resolution chart · PNG

JRI ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Nuveen Real Asset Income and Growth Fund Common Shares of Beneficial Interest EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
29.511%
18.099%
145.9251%
398.8056%
1,626.0695%
-131.8925%
-101.0751%
-43.0788%
41.0841%
-8.0679%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.